骨髓间充质干细胞治疗心肌梗死的困惑与争议

doi:10.3969/j.issn.1674-490X.2009.06.027

医学研究与教育 ›› 2009, Vol. 26 ›› Issue (6): 74-76.DOI: 10.3969/j.issn.1674-490X.2009.06.027

骨髓间充质干细胞治疗心肌梗死的困惑与争议

瞿海龙¹,彭广军¹,麻晓静²,张冰¹,曹国辉¹

1.河北大学附属医院急诊科,河北保定,071000
2.保定同济男科医院内科,河北保定,071000

收稿日期:2016-10-09 修回日期:2016-10-09 出版日期:2009-12-25 发布日期:2009-12-25

Received:2016-10-09 Revised:2016-10-09 Online:2009-12-25 Published:2009-12-25

摘要/Abstract

摘要： 1999年Makino等[1]首次在体外应用5-氮胞杂苷(5-Aza)将骨髓间充质干细胞(mesenchymal stem cells MSCs)定向分化成心肌细胞,为MSCs移植治疗心肌梗死提供了细胞生物学基础.2001年,Orlic等[2]将Lin-C-Kit+干细胞注射到心肌梗死小鼠的存活心肌内,发现其分化为心肌样细胞,开创了干细胞在体内移植治疗心肌梗死的先河.

中图分类号:

R541

瞿海龙,彭广军,麻晓静,张冰,曹国辉. 骨髓间充质干细胞治疗心肌梗死的困惑与争议[J]. 医学研究与教育, 2009, 26(6): 74-76.

[1] 陈晓春, 单鸿伟, 瞿海龙, 葛均波, 葛智平, CHEN Xiao-chun, SHAN Hong-wei, QU Hai-long, GE Jun-bo, GE Zhi-ping. 骨髓间充质干细胞移植加重大鼠主动脉血管成形术后再狭窄程度 [J]. 中华心血管病杂志 2007.doi:10.3760/j.issn:0253-3758.2007.09.005
[2] Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. [J]. The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation 1999, 5(5).
[3] Orlic D, Kajstura J, Chimenti S. Bone marrow cells regenerate infarcted myocardium [J]. Nature 2001, 410(6829).
[4] Breitbach M, Bostani T, Roell W. Potential risks of bone marrow cell transplantation into infarcted hearts [J]. Blood 2007, 110(04).
[5] Murry C E, Soonpaa M H, Reinecke H. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts [J]. Nature 2004, 428(6983).
[6] Thoelen M, Vandenabeele F, Rummens JL. Ultrastruc-ture of transplanted mesenchymal stem cells after acute myocardial infarction [J]. Heart 2004, 90(09).
[7] Perin E C, Dohmann H F, Borojevic R. Transendo-cardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure [J]. Circulation 2003, 107(18).
[8] Furlani D, Li W, Pittermann E. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. [J]. Cell transplantation 2009, 3(3).
[9] Strauer B E, Brehm M, Zeus T. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction [J]. Dtsch Med Wo-chenschr 2001, 126(34-35).
[10] Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS, Martin BJ, Quyyumi AA, Few WL, Kin H, Guyton RA, Vinten-Johansen J. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. [J]. Basic Research in Cardiology: Official Journal of the German Association of Cardiovascular Research 2008, 6(6).
[11] Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. [J]. Nature medicine 2001, 4(4).
[12] Hu X, Wang J, Chen J, Luo R, He A, Xie X, Li J. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. [J]. European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery 2007, 3(3).
[13] Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L, Wang K, Zou Y. [J]. Basic Research in Cardiology: Official Journal of the German Association of Cardiovascular Research 2005.
[14] Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. [J]. Journal of Cellular Physiology 1996, 3(3).
[15] Tang Y L, Zhao Q, Qin X. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction [J]. Annals of Thoracic Surgery 2005, 80.
[16] Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, Lill MC, Frantzen M, Takizawa K, Chen LS, Fishbein MC, Sharifi BG, Chen PS, Makkar R. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. [J]. Journal of cardiovascular electrophysiology 2003, 8(8).
[17] Guo J, Lin G S, Bao C Y. Anti-inflammation role for mesenchymal stem cells transplantation in myocardial in-farction [J]. Inflammation 2007, 30(3-4).
[18] Wollert KC, Meyer GP, Lotz J, Ringes Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. [J]. The Lancet 2004, 9429(9429).

骨髓间充质干细胞治疗心肌梗死的困惑与争议

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

[1]	张丽美, 王国强, 陈世娇, 许金鹏, 宋书江. RhoA/ROCK信号通路与心血管系统疾病关系的研究进展[J]. 医学研究与教育, 2021, 38(2): 8-13.
[2]	应陈艇,樊紫瑜,牛小龙. 小型猪慢性心力衰竭模型研究进展[J]. 医学研究与教育, 2016, 33(5): 40-43.
[3]	张兰芳,贾新未,王占启,解俊敏,韩昆鹏. 瑞舒伐他汀联合地尔硫卓对急性心肌梗死患者直接PCI治疗的心肌保护作用[J]. 医学研究与教育, 2016, 33(3): 1-5.
[4]	张兰芳,贾新未,王占启,解俊敏,韩昆鹏. 瑞舒伐他汀联合地尔硫卓对急性心肌梗死患者直接PCI治疗的心肌保护作用[J]. 医学研究与教育, 2016, 33(3): 1-5.
[5]	李苗苗,王彦. 冠心病患者二级预防用药依从性的研究进展[J]. 医学研究与教育, 2014, 31(4): 81-87.
[6]	孙猛,柳克晔,刘福林,周晓东,韩喆,周程. 心脏型脂肪酸结合蛋白敏感性在急性冠脉综合征早期诊断中的作用[J]. 医学研究与教育, 2011, 28(1): 28-30,44.
[7]	王海洋,范新发,冯浩楼,崔玉英. 中医药治疗冠心病高凝状态研究现状与前景展望[J]. 医学研究与教育, 2010, 27(1): 85-88.